Archives

by in
Entry Author Date Location
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
ZS Pharma Raises $55M to Develop Drug to Treat Hyperkalemia 03/06/14 Texas
With Gene Therapy, VentriNova Aims to Mend Broken Hearts 03/04/14 New York
Rebooted Texas Cancer Agency Funds Biotech Firms 02/28/14 Texas
BioHouston Life Science Forum Spotlights Texas Biotech Innovation 02/24/14 Texas
Isis Shares Climb on Early Data for Rare Spine Disorder Drug 02/21/14 Boston
Austin’s Lumos Pharma Gets $14M for Creatine Disorder Therapy 02/07/14 Texas
Texas Biotech Leaders Doubt CPRIT Will Get Its Groove Back 01/24/14 Texas
Promentis’s $2.9M Series B Round to Fund Human Trials 01/16/14 Wisconsin
Akili, Pfizer, and the Rise of Videogame Brain Therapies 01/09/14 Boston
Intercept Shares Skyrocket After Liver Drug Nails Mid-Stage Study 01/09/14 New York
Janssen Tests Ideas, Apps, in Bid for Clinical Trials Innovation 01/08/14 San Diego
Investors Sink Tesaro Shares on Phase 3 Misses For Cancer Drug 12/23/13 Boston
Texas Roundup: Apollo Endosurgery, Pros Holdings, START 12/20/13 Texas
How WARF Plans to Stay Relevant in Lean Times for Tech Transfer 12/20/13 Wisconsin
Radius Health Churns Through 3 CEOs, as Osteoporosis Drug Delayed 12/20/13 Boston
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
Cubist Shares Climb As Antibiotic Scores in Phase 3 Again 12/16/13 Boston
Cubist’s Calixa Buyout Bears Fruit as Antibiotic Hits First Phase 3 Mark 11/25/13 Boston
ZS Pharma Passes Key Test With Drug for Hyperkalemia 11/20/13 Texas
Futuristic “Human-on-Chip” Models Will Help Drug Development 11/19/13 National
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Sarepta Shares Crumble As FDA Calls New Drug Application “Premature” 11/12/13 Boston
Zalicus Pain Drug Flops in Two Key Clinical Studies 11/11/13 Boston
Zalicus Awaits Day of Reckoning, Braces For Key Pain Drug Results 11/11/13 Boston
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More 11/08/13 Boston
Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical Hold 11/06/13 Boston
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Atterocor Begins Phase 1 Trial for Adrenal Cancer Drug 11/01/13 Detroit
Ariad Pulls Cancer Drug Off the Market as Trial Fallout Continues 10/31/13 Boston
Page 2 of 12 « previous page · next page »